College of Clinical Medicine for Oncology, Fujian Medical University, 420 Fuma Rd, Jin'an District, Fuzhou, 350014, Fujian, China.
Department of Hematology-Oncology, Fujian Children's Hospital, Fuzhou, 350014, Fujian, China.
Radiat Oncol. 2022 May 13;17(1):95. doi: 10.1186/s13014-022-02064-9.
This study aimed to explore the pattern of locoregional recurrence after surgery in patients with non-metastatic stage pT4 sigmoid colon cancer and the role of adjuvant radiotherapy on survival.
We retrospectively analyzed data from 208 patients who underwent surgery in our hospital. The patients were randomly divided into training and validation groups at a 1:1 ratio. Patients at high risk for locoregional recurrence were screened using Cox regression analysis. Based on the data of 2,886 patients in the Surveillance, Epidemiology, and End Results (SEER) database, the effect of adjuvant radiotherapy on overall survival (OS) and cancer-specific survival (CSS) was evaluated by Kaplan-Meier curves.
Of the 208 patients, 57 (27.4%) presented with locoregional recurrences (14 anastomotic and 43 abdominal or pelvic lymph node recurrences). Multivariate analysis showed that serum CEA, differentiation, lymph node dissection number, and N stage were independent predictors of locoregional recurrence-free survival (all p < 0.05). A risk-stratification model was constructed, and a total score of ≥ 6.5 points was considered the high-risk group for locoregional recurrence. Both the training and validation sets presented that the model had a good predictive ability (area under the curve = 0.828 and 0.724, respectively). Analysis of SEER data revealed that adjuvant radiotherapy significantly prolonged OS and CSS in the high-risk population (all p < 0.05, vs. no radiotherapy).
Patients with a total risk score of 6.5 or more had a high likelihood of locoregional recurrence, and perhaps adjuvant radiotherapy could improve their survival.
本研究旨在探讨非转移性 pT4 乙状结肠癌患者手术后局部区域复发的模式以及辅助放疗对生存的作用。
我们回顾性分析了 208 例在我院接受手术的患者数据。患者以 1:1 的比例随机分为训练组和验证组。使用 Cox 回归分析筛选局部区域复发高风险患者。基于 2886 例来自 Surveillance, Epidemiology, and End Results(SEER)数据库的患者数据,通过 Kaplan-Meier 曲线评估辅助放疗对总生存(OS)和癌症特异性生存(CSS)的影响。
在 208 例患者中,57 例(27.4%)出现局部区域复发(14 例吻合口复发,43 例腹部或盆腔淋巴结复发)。多变量分析显示,血清 CEA、分化、淋巴结清扫数目和 N 分期是局部区域无复发生存的独立预测因素(均 p<0.05)。构建了风险分层模型,总评分≥6.5 分被认为是局部区域复发的高危组。训练组和验证组均表明该模型具有良好的预测能力(曲线下面积分别为 0.828 和 0.724)。SEER 数据分析显示,辅助放疗显著延长了高危人群的 OS 和 CSS(均 p<0.05,与无放疗相比)。
总风险评分达到 6.5 分或更高的患者局部区域复发的可能性较高,或许辅助放疗可以改善他们的生存。